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OBJECTIVES We investigated the feasibility of myocardial contrast echocardiography (MCE) to evaluate
regional perfusion after bone marrow cell transplantation.
BACKGROUND The myocardial microvessels improved by cell transplantation are too small to visualize with
conventional angiography.
METHODS Fourteen mini-pigs from the Nippon Institute for Biological Science were used. The proximal left
anterior descending coronary artery was ligated. One month later, nine pigs survived. Six pigs
received autologous cell transplantation into the left ventricular anterior wall: bone marrow
mononuclear cells (BMMNCs) (n  3) and bone marrow stromal cells (BMSCs) (n  3). The
other three pigs received saline (control group, n  3). The pigs were sacrificed one month later.
Myocardial contrast intensity (MCI) with a contrast agent was measured using the SONOS 5500
system (Philips). Capillary density (CD) and MCI were measured at four areas: anteroseptum
(nontransplanted infarct area), anterior wall (transplanted infarct area), septum (border zone), and
lateral wall (normal). We compared the anteroseptum with the anterior wall by MCI and CD.
RESULTS In the BMMNC and BMSC subsets, the CD of the anterior wall was higher than that of the
anteroseptum (p  0.001). There was a linear relation between MCI and CD (acoustic unit
[AU2]  0.234 CD  0.010, r  0.92, p  0.001). At one month after cell transplantation,
MCI of the anterior wall increased in the BMMNC and BMSC subsets (p  0.05), although
it did not change in the control group. The ratio of wall thickness (systole/diastole) in the
transplanted infarct area was larger than that in the nontransplanted infarct area (p  0.01).
CONCLUSIONS Myocardial contrast echocardiography is useful to evaluate regional perfusion, which was
enhanced by bone marrow cell transplantation. (J Am Coll Cardiol 2004;43:1299–305)
© 2004 by the American College of Cardiology Foundationi
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keveral researches reported that bone marrow cell transplan-
ation into the heart induced angiogenesis (1–4). Assess-
ent of myocardial perfusion after therapy is important. For
long time, vascular density on histologic study has been
sed to evaluate the therapeutic effectiveness of cell trans-
lantation on myocardial infarction (MI) in experimental
tudies (5). However, it is invasive and difficult to perform
biopsy of the targeted area in clinical examinations.
Microvessels induced by bone marrow cell transplanta-
ion are too small (50 m) to visualize using conventional
ngiography (2,6). Although previous studies have found
one marrow cell transplantation to be effective, concrete
nd objective evidence for this therapy in daily clinical
xaminations has not been demonstrated.
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Manuscript received July 11, 2003; revised manuscript received September 1, 2003,(ccepted September 16, 2003.Myocardial contrast echocardiography (MCE) is a non-
nvasive and inexpensive tool to evaluate myocardial perfu-
ion in the microvasculature (7,8), and it can be performed
ven at the bedside. The purposes of this study were to
erify the feasibility of MCE and to evaluate angiogenesis
fter bone marrow cell transplantation in the chronic isch-
mic heart of pigs.
ETHODS
nimal model. All animals received humane care in com-
liance with the “Principles of Laboratory Animal Care,”
ormulated by the National Society for Medical Research,
nd the “Guide for the Care and Use of Laboratory
nimals,” prepared by the Institute of Laboratory Animal
esources and published by the National Institutes of
ealth (NIH Publication No. 86-23, revised 1985). All
rocedures were approved by the Animal Care Committee
f the National Cardiovascular Center, Osaka, Japan.
Fourteen mini-pigs (weight 25 to 30 kg) from the
ippon Institute for Biological Science (NIBS; Nosan
orp., Japan) were used. The pigs were premedicated with
etamine hydrochloride (600 mg intramuscularly), stressnyl
2 ml), and atropine (1.5 mg) (9). Anesthesia was induced
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MCE for Bone Marrow Cell Transplantation April 7, 2004:1299–305sing a ventilation mask with 1% to 3% isoflurane, oxygen
t 10 l/min, and ketamine hydrochloride (12 to 15 mg/kg
ntravenously). The animals were intubated using a cuffed
ndotracheal tube and were ventilated with 50% oxygen to
aintain end-tidal CO2 between 30 and 35 mm Hg.
nesthesia was maintained with 0.5% to 1.0% isoflurane in
xygen at a flow rate of 3 to 4 l/min and fraction of inspired
xygen (FIO2) at 50%. Electrocardiography was used to
onitor the heart rate, rhythm, and ST-segment changes
uring the surgical procedure.
Under general anesthesia, a left lateral thoracotomy was
erformed. The left anterior descending coronary artery was
ouble-ligated with 2-0 silk (2). Ventricular fibrillation and
achycardia were treated with xylocaine and a defibrillator.
fter the lungs were adequately inflated, the pericardium
as closed using 4-0 prolene sutures, and the chest was
losed with #1 prolene. A 10-ml volume of sternal bone
arrow was aspirated for culture. The pigs were weaned
rom anesthetics, extubated, and kept warm in a pen. The
urgical team administrated analgesic to the pigs, if needed.
By one month after MI, 5 of the 14 pigs had died. The
ine pigs that survived were randomized as follows. Six of
he nine pigs were assigned to a cell transplantation group
hose subsets were bone marrow mononuclear cells
BMMNCs) (n  3) and bone marrow stromal cells
BMSCs) (n  3). The other three pigs received saline
control group, n  3) (9).
ell preparation. BONE MARROW MONONUCLEAR CELLS. In
he BMMNC subset, at one month after MI, immediately
efore cell transplantation, 50 to 100 ml of fresh bone
arrow was aspirated and loaded onto Lymphoprep
AXIS-SHIELD PoC AS, Oslo, Norway) (2). The solution
as centrifuged at 800g at 4°C for 20 min. A white layer was
spirated and washed with phosphate-buffered saline twice,
nd 1  108 cells/ml was created.
ONE MARROW STROMAL CELLS . A 10-ml volume of bone
arrow was aspirated from the sternum on the same day as
I and then cultured in cell culture medium: Iscove’s
odified Dulbecco’s medium with 10% fetal bovine serum,
enicillin G (100 U/ml), streptomycin (100 g/ml), and
mphotericin B (0.2 g/ml) (9). The cells were incubated
ith 95% air and 5% CO2 at 37°C for one month.
The cultured BMSCs were dissociated from the culture
ish with 0.05% trypsin in phosphate-buffered saline, col-
Abbreviations and Acronyms
AU  acoustic unit
BMMNC  bone marrow mononuclear cell
BMSC  bone marrow stromal cell
CD  capillary density
MCE  myocardial contrast echocardiography
MCI  myocardial contrast intensity
MI  myocardial infarctionected, and centrifuged at 570g. The cells were then sus- eended to obtain a concentration of 1  108 cells in 1.0 ml.
his suspension was injected in the same pig as registered in
his BMSC subset.
Under general anesthesia, we performed bone marrow
ell transplantation after a median sternotomy. We longi-
udinally opened the pericardium, exposing the heart to
isualize the left anterior descending and diagonal arteries,
o that we could recognize where the anterior wall was.
one marrow cells were autologously injected using a
7-gauge needle with a 1-ml syringe. We made sure that the
ip of the needle was not intracavitary with negative pressure
hen using the syringe and then injected each 0.1-ml cell
olution of 108 cells/ml at each of the 10 sites on the left
entricular anterior free wall at the mid-ventricle.
yocardial contrast echocardiography. A specialist in
CE performed MCE at two stages: one month after
nfarction (before cell transplantation) and one month after
ell transplantation. A SONOS 5500 system (Philips, An-
over, Massachusetts) was used (2,10). All imaging was
erformed at the mid-papillary muscle level of the left
entricle, under a closed-chest condition. The MCE imag-
ng was performed in the second harmonic mode, in which
ltrasound was transmitted at 1.8 MHz and received at 3.6
Hz. The mechanical index was set at 1.4 to 1.6. The
aximal dynamic range was 60 dB. As a venous contrast
gent, we used the second-generation microbubbles called
M-454 (Definity, Bristol-Myers Squibb Medical Imaging
nc., North Billerica, Massachusetts) (8). They are com-
osed of a bilayer phospholipid shell and perfluoropropane.
he mean size of gas-filled liposomes is about 2.5 m. This
gent was injected intravenously at a rate of 100 l/min. We
sed the intermittent mode and the multiframe trigger
ethod in MCE, and we set the trigger point at the
nd-systolic phase every 4 beats in this study.
Data were recorded on 1.25-cm videotape with an
-VHS recorder and on a 5-inch magnetic optical disk
11,12) and analyzed off-line using QuantiCon (Echotech
D Imaging Systems, GmbH, Hallbergmoos, Germany).
e put the region of interest on targeted areas and
alculated their myocardial intensities. We subtracted the
ntensity of phase B from that of phase A at a target. Phase
occurred when the microbubbles sufficiently filled the
yocardium, and phase B occurred when about 80% of
icrobubbles were destroyed by a series of three frames of
he ultrasound beam within the end-systolic phase. We
egarded this subtracted intensity as myocardial contrast
ntensity (MCI) for analysis. The acoustic unit (AU) was
etermined using the Acoustic densitometry software pack-
ge (Philips), which displays intensities in dB (13). Acoustic
ensitometry provides an integrated on-line capability to
easure, display, and analyze the average acoustic image
ntensity. Off-line densitometric systems that offer a “digi-
al” solution for data storage using magnetic/optimal disk
edia are also plagued with the problem of nonlinearity in
he image data (13). We calculated AU2 from dB using the
60dB	/ 20quation: y[AU]  255  10 	, and we
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April 7, 2004:1299–305 MCE for Bone Marrow Cell Transplantationssessed myocardial intensity using AU2. We put the region
f interest on four different target areas for measurement of
ntensity: anteroseptum (nontransplanted infarct area), an-
erior wall (transplanted infarct area), septum (border area),
nd lateral wall (normal area). At these four target areas,
CI and capillary density (CD) were measured and com-
ared.
all thickness. To evaluate wall motion, we measured the
all thickness of the systolic and diastolic phases at the
nteroseptum (nontransplanted infarct area), anterior wall
transplanted infarct area), and lateral wall (normal area).
e calculated the wall thickness (systole/diastole) ratio and
ssessed the regional wall motion.
istologic studies (CD). At one month after cell trans-
lantation, we performed MCE to assess MCI, after which
he heart was arrested with potassium chloride and excised
or histologic study. The coronary arteries were then per-
used with 10% formaldehyde (100 ml), and the heart was
mmersed in the formaldehyde for 20 days.
After fixation, a cube (5  10  10 mm) of tissue from
ach site, where MCE was evaluated, was embedded in
araffin and cut into 6-m sections for staining with
ematoxylin-eosin, as described in the manufacturer’s spec-
fications (Sigma Chemical Co., St. Louis, Missouri), and
on Willebrand factor-related antigen (14). A pathologist
nd an orthopedist investigated bone formation and tumor-
able 1. Capillary Density One Month After Cell
ransplantation
Subset No.
Normal
Area*
Nontransplanted
Infarct Area†
Transplanted
Infarct Area‡
MMNC-1 1.98 0.768 1.60
MMNC-2 2.14 0.576 2.44
MMNC-3 0.92 0.704 1.28
MSC-1 2.53 0.461 0.55
MSC-2 2.10 0.384 1.47
MSC-3 1.69 0.359 1.86
ontrol-1 2.91 0.218 0.26
ontrol-2 2.18 0.282 0.21
ontrol-3 2.62 0.346 0.36
natomic portion: *lateral wall, †anteroseptum, and ‡anterior wall.
BMMNC  bone marrow mononuclear cell subset; BMSC  bone marrow
tromal cell subset; control  control group.
able 2. Myocardial Contrast Intensity (AU2) One Month
fter Cell Transplantation
Subset No.
Normal
Area*
Nontransplanted
Infarct Area†
Transplanted
Infarct Area‡
MMNC-1 0.496 0.146 (0.130) 0.460 (0.110)
MMNC-2 0.553 0.167 (0.192) 0.635 (0.210)
MMNC-3 0.201 0.149 (0.121) 0.127 (0.133)
MSC-1 0.697 0.110 (0.179) 0.146 (0.217)
MSC-2 0.401 0.124 (0.183) 0.450 (0.118)
MSC-3 0.383 0.142 (0.192) 0.440 (0.101)
ontrol-1 0.710 0.092 (0.152) 0.127 (0.167)
ontrol-2 0.644 0.146 (0.171) 0.099 (0.142)
ontrol-3 0.764 0.130 (0.130) 0.121 (0.127)
natomic portion: *lateral wall, †anteroseptum, and ‡anterior wall. The numbers in
arentheses indicate myocardial contrast intensity before cell transplantation.rAbbreviations as in Table 1.genic formation. An observer blinded to the treatment
roups and subsets determined the CD of the anteroseptum
nontransplanted infarct area), anterior wall (transplanted
nfarct area), septum (border area), and lateral wall (normal
rea). Five fields of each section were randomly selected, and
he CD was averaged and expressed as the number of blood
essels per mm2 (15).
tatistical methods. Data are expressed as the mean value
SD. Interstage comparisons in each group and intrastage
ifferences between two groups were confirmed using the
ann-Whitney U test. Analysis System software (Statcel,
MS Publishing Company, Tokorozawa, Saitama, Japan)
as used for these two analyses. Correlations were per-
ormed using logarithmic or linear regression analysis.
ifferences were considered significant at p  0.05.
ESULTS
here was no critical arrhythmia before, during, or after cell
ransplantation. Heart rate and blood pressure were stable
uring transplantation. The nine pigs that survived for one
onth after MI completed the whole procedure.
apillary density and MCI of normal, nontransplanted
nfarct, and transplanted infarct areas. The CD of the
ormal area was 2.12 
 0.58 (103/mm2) and that of the
ontransplanted infarct area was 0.46 
 0.19 (103/mm2)
Table 1). The MCI of the normal area was 0.54 
 0.19 and
hat of the nontransplanted infarct area was 0.13 
 0.02
Table 2). Both the CD and MCI of the normal area were
ignificantly higher than those of the nontransplanted in-
arct area (p  0.00035 and p  0.00035, respectively).
On the transplanted infarct area, the CD of the trans-
lant group (including the BMMNC and BMSC subsets)
as 1.53 
 0.63 (103/mm2) and that of the control group
as 0.27 
 0.07 (103/mm2) (Table 1). On the same area,
he MCI of the transplant group was 0.38 
 0.20 and that
f the control group was 0.12 
 0.02 (Table 2).
The CD and MCI of the transplanted infarct area in the
ransplant group were significantly higher than those of the
ame area in the control group (p  0.020 and p  0.028,
able 3. Ratio of Wall Thickness (Systole/Diastole)
Subset No.
Normal
Area*
Nontransplanted
Infarct Area†
Transplanted
Infarct Area‡
MMNC-1 1.4 1.0 1.5
MMNC-2 1.4 1.2 1.4
MMNC-3 1.6 1.1 1.6
MSC-1 1.4 1.0 1.3
MSC-2 1.7 1.0 1.7
MSC-3 1.7 1.2 1.4
ontrol-1 1.4 1.0 1.0
ontrol-2 1.4 1.0 1.0
ontrol-3 1.3 1.1 1.0
natomic portion: *lateral wall, †anteroseptum, and ‡anterior wall.
Abbreviations as in Table 1.espectively).
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MCE for Bone Marrow Cell Transplantation April 7, 2004:1299–305all thickness ratio (systole/diastole) of normal, non-
ransplanted infarct, and transplanted infarct areas. The
all thickness systolic/diastolic ratio at the normal area was
ignificantly larger than that at the nontransplanted infarct
rea (1.50 
 0.18 and 1.07 
 0.09, respectively; p 
.0003) (Table 3). In the cell transplant group, the wall
hickness systolic/diastolic ratio at the transplanted infarct
rea was significantly larger than that at the nontransplanted
nfarct area (1.48 
 0.15 and 1.08 
 0.1, respectively; p 
.004), although there was no difference in the control
roup. Further, when we compared the systolic/diastolic
atio between the cell transplant group and control group at
he transplanted infarct area, the ratio in the transplant
roup was significantly larger than that in control group
1.48 
 0.15 and 1 
 0, respectively; p  0.02) (Table 3).
omparison of CD in nontransplanted and transplanted
nfarct areas. The histologic findings of the section stained
or von Willebrand factor are shown in Figure 1. In both the
MMNC and BMSC subsets, the anteroseptum (nontrans-
lanted infarct area) contained very few capillaries (Fig. 1
1a and 2a]). In contrast, the anterior wall (transplanted
nfarct area) contained more capillaries than the anterosep-
um (Figs. 1 [1b and 2b]). The size of the capillaries at the
ransplanted infarct area ranged from 5 to 20 m, which
aried more than that of the normal area (10 to 20 m).
one formation or tumorigenic formation was not observed
t the transplanted area in any pig.
In the cell transplant group, the CD of the anterior
all was significantly larger than that of the anterosep-
igure 1. Capillary formation at the anteroseptum and anterior wall. Numb
represents the bone marrow stromal cell (BMSC) subset; and number 3
hows the findings of the anteroseptum (nontransplanted infarct area), and
nfarct area). In the BMMNC and BMSC subsets, the anterior wall (1b, 2
ontrol group, both the anteroseptum (3a) and anterior wall (3b) containeum (p  0.0081) (Fig. 2A) (BMMNC subset, p  w.025; BMSC subset, p  0.025) (Fig. 2B). In the
ontrol group, the CD of both the anterior wall and
nteroseptum was low, and there was no significant
represents the bone marrow mononuclear cell (BMMNC) subset; number
esents the control group (magnification 200). The top row (1a, 2a, 3a)
om row (1b, 2b, 3b) shows the findings of the anterior wall (transplanted
tained more capillaries than the anteroseptum (1a, 2a). In contrast, in the
y few capillaries.
igure 2. The capillary density (CD) of the anteroseptum (open bars) and
nterior wall (solid bars). The CD of the anterior wall was higher than that
f the anteroseptum in the cell transplant group (**p  0.0081; A) (*p 
.025 and *p  0.025 for bone marrow mononuclear cell (BMMNC) and
one marrow stromal cell (BMSC) subsets, respectively; B), although thereer 1
repr
bott
b) conas no difference between the two areas in the control group (A).
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April 7, 2004:1299–305 MCE for Bone Marrow Cell Transplantationifference between the two areas (p  NS) (Fig. 2A). The
D of the anteroseptum in the BMMNC subset was
arger than that of the other subset or group (p  0.027).
elationship between MCI and CD. Figure 3 shows
ypical graphs of the four target areas at one month after
MMNC transplantation. The MCI of the anterior wall
transplanted infarct area) was higher than that of the
nteroseptum (nontransplanted infarct area). The MCI
nd CD of four target areas at the same stage were
lotted (Fig. 4).
The MCI and histologic CD correlated well based on
ata derived from four areas of all pigs. When MCI was
nalyzed by decibel, MCI and CD were correlated logarith-
ically (dB  7.32Log[CD]  5.89; r  0.90, p  0.001)
Fig. 4A). There was a significant linear relation between
CI analyzed by AU2 and CD (MCI [AU2]  0.23 CD 
.01; r  0.92, p  0.001) (Fig. 4B).
ime course of MCI. In the control and cell transplant
roups, there was the same time trend of MCI at the
nteroseptum (nontransplanted infarct area), which slightly
ecreased (p  NS) (Fig. 5A). In contrast, the MCI of the
nterior wall (transplanted infarct area) significantly in-
igure 3. The myocardial contrast intensity (MCI) of the bone marrow m
nable us to quantify MCI and to recognize the differences in the anterose
igher than that in the anteroseptum.preased in the cell transplant group (p  0.018), although it
id not change in the control group (p  NS) (Fig. 5B).
ISCUSSION
he importance of this study is to establish a method to
ollow the effect of bone marrow cell transplantation not
nly in experimental studies but also in clinical examina-
ions. Therefore, we performed MCE using Definity as the
ontrast agent and a commercially available ultrasound
achine, based on the hypothesis that MCE would be a
seful tool to assess the microcirculation after cell transplan-
ation.
This study demonstrated that: 1) MCI measured by
CE was closely correlated with CD; 2) bone marrow cell
ransplantation increased blood perfusion at the infarct area;
nd 3) bone marrow cell transplantation into the heart was
erformed safely.
elationship between MCI and CD for assessment of
yocardial perfusion. The relationship between MCI and
D showed a strong correlation. This result indicates that
CE is as useful as CD for evaluating angiogenesis. In
clear cell subset at one month after cell transplantation. The four graphs
anterior wall, septum, and lateral wall. The MCI in the anterior wall wasononu
ptum,revious experimental studies, CD or microsphere analysis
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MCE for Bone Marrow Cell Transplantation April 7, 2004:1299–305as generally used to assess angiogenesis (8,16). However,
n clinical examinations, we cannot use these two methods.
n contrast, MCE is a noninvasive and repeatable method to
valuate angiogenesis induced by bone marrow cell trans-
lantation to the heart for clinical application.
The microsphere method reflects functional myocardial
erfusion. There are several reports stating that MCI using
CE reflects myocardial perfusion using the microsphere
ethod (11,17). Therefore, MCI reflects functional myo-
ardial perfusion.
Recently, it was reported that MCI evaluated by AU2 is
roportional to the concentration of microbubbles (13). In
his study, we proved that MCI evaluated by AU2 is
roportional to CD. This result indicates that the new
icrovessels created by bone marrow cell transplantation
ere functional.
mportance of angiogenesis by bone marrow cell trans-
lantation. Bone marrow cell transplantation (BMMNCs
nd BMSCs) induced angiogenesis in the transplanted area, as
roved by CD and MCI. The angiogenesis induced by bone
arrow cell transplantation may make the residual cardiac
uscle and transplant cells survive, which may contribute to
igure 4. Relationship between myocardial contrast intensity (MCI) and
apillary density (CD). (A) When MCI was evaluated by dB, a logarithmic
elation was seen between MCI and CD. (B) When MCI was evaluated by
U2, a linear relation was seen between them.mprovement of contraction (1).he BMMNC subset. The BMMNCs contain various
inds of cells, such as hematopoietic cells, fibroblasts,
yogenic cells, and endothelial cells, and they can work
eneficially in the ischemic myocardium (12). This study
as consistent with our previous result (1). We observed
ngiogenesis, as described earlier, and did not see any bone
ormation. The BMMNCs have several advantages. Special
acilities are not required because we can process them fresh
y a clinically established protocol. This procedure is simple
nd can be performed safely.
he BMSC subset. The BMSCs were cultured by
aplan’s method, as previously reported (9,18). The BM-
Cs can be isolated from the other cells in marrow by their
endency to adhere to the culture dish. Stromal cells were a
eterogeneous population (1). Our study suggested that the
MSCs could include stem cells differentiating into endo-
helial cells due to an increase in CD and improvement of
yocardial perfusion.
The potential mechanisms inducing angiogenesis after
ndothelial cell transplantation are formation of blood
essels by transplanted endothelial cells and stimulation of
ngiogenesis by growth factors such as vascular endothelial
rowth factor, beta-fibroblast growth factor, and insulin-
ike growth factor-1 (2), expressed or stimulated by trans-
lanted endothelial cells (15).
igure 5. Time course of myocardial contrast intensity (MCI) in the
nteroseptum and anterior wall before and after transplantation. The
traight line indicates the cell transplant group (bone marrow mononuclear
ell and bone marrow stromal cell subsets), and the dashed line indicates
he control group. (A) At the anteroseptum (nontransplanted infarct area),
here was no significant change between the groups or stages. (B) At the
nterior wall (transplanted infarct area), the MCI of the cell transplant
roup significantly increased after transplantation (*p  0.018), although
hat of the control group did not change.The BMSCs can be cultured from only 10 ml of bone
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April 7, 2004:1299–305 MCE for Bone Marrow Cell Transplantationarrow; however, it takes time to expand and requires
ulture facilities satisfying good manufacturing practice for
linical applications.
ffects of BMMNC and BMSC transplantation. The
ncreases in CD and MCI after cell transplantation were
ecognized in both the BMMNCs and BMSCs. The
MSCs stimulated angiogenesis as fresh bone marrow cells
BMMNCs), as in our previous rat study (1). The signifi-
ant increases in CD and MCI at the transplanted infarct
rea indicated that bone marrow cell transplantation im-
roved regional perfusion where cells were injected in both
MMNC and BMSC subsets.
all motion after cell transplantation. In the cell trans-
lant group, the regional wall motion of the transplanted
nfarct area was significantly improved after cell transplanta-
ion. This result indicates that improvement of perfusion after
one marrow cell transplantation is reflected in regional wall
otion where bone marrow cells are transplanted.
ollow-up MCE after cell transplantation. The MCI
sing MCE enabled us to assess the effects of this therapy
ot only by comparing the transplanted infarct area with the
ontransplanted infarct area, but also by comparing the
ransplanted infarct area before and after cell transplanta-
ion; therefore, it is useful for follow-up after this therapy.
one marrow cell transplantation for clinical application.
one marrow cell transplantation was performed safely in our
tudy. During the acute phase (perioperative period), there
ere no detrimental effects such as hypotension, arrhythmia, or
ypoxemia. During the subchronic phase, there was no critical
rrhythmia. There was no ectopic differentiation (bone forma-
ion) or tumorigenic formation at the transplant sites. From the
oint of view of clinical application, we regarded both the
MMNC and BMSC transplantations as feasible.
tudy limitations. The sample size of this study is low at
he subset level. The bone marrow cell transplantation
roup was composed of BMMNC and BMSC subsets, and
ot only was their wall motion statistically improved after
ell transplantation, but also their CD and MCI were
tatistically higher than those in the nontransplanted area.
his project is adequately powered by statistical analysis.
We measured CD and MCI only at one month after cell
ransplantation. It will be necessary to evaluate myocardial
erfusion and especially cardiac function in the long term.
onclusions. We proved that bone marrow cell transplan-
ation improved the regional perfusion in the chronic
schemic heart. Because angiogenesis after cell transplanta-
ion is the most important factor that improves myocardial
ondition, MCI using noninvasive MCE could be a prom-
sing tool to evaluate functional perfusion after bone marrow
ell transplantation in the clinical setting.
cknowledgments
e thank Mr. K. Masuda, Ms. E. Takeda, and Dr. H.
shibashi-Ueda for their technical assistance in the histo-
ogic study, as well as Ms. K. Hattori for her help in
erforming surgical procedures. We also thank Dr. H.hgushi (Tissue Engineering Research Center, National
nstitute of Advanced Industrial Science of Technology,
apan) for the investigation of bone formation and tumor-
genic formation.
eprint requests: Dr. Soichiro Kitamura, President of National
ardiovascular Center, Chairman of Department of Cardiovascu-
ar Surgery, 5-7-1 Fujishirodai, Suita, Osaka, 565-8565 Japan.
-mail: skitamura@hsp.ncvc.go.jp.
orrespondence: Dr. Shinji Tomita, Cardiothoracic Surgical
nit, Auckland City Hospital, Private Bag 92024, Auckland, New
ealand. E-mail: shinjitomita@hotmail.com.
EFERENCES
1. Tomita S, Li RK, Weisel RD, et al. Autologous transplantation of
bone marrow cells improves damaged heart function. Circulation
1999;100 Suppl II:II247–56.
2. Kamihata H, Matsubara H, Nishiue T, et al. Implantation of bone
marrow mononuclear cells into ischemic myocardium enhances collat-
eral perfusion and regional function via side supply of angioblasts,
angiogenic ligands, and cytokines. Circulation 2001;104:1046–52.
3. Hulspas R, Quesenberry PJ. Characterization of neurosphere cell
phenotypes by flow cytometry. Cytometry 2000;40:245–50.
4. Hamano K, Li TS, Kobayashi T, et al. Therapeutic angiogenesis
induced by local autologous bone marrow cell implantation. Ann
Thorac Surg 2002;73:1210–5.
5. Edelberg JM, Lee SH, Kaur M, et al. Platelet-derived growth
factor-AB limits the extent of myocardial infarction in a rat model:
feasibility of restoring impaired angiogenic capacity in the aging heart.
Circulation 2002;105:608–13.
6. Feinstein SB, Shah PM, Bing RJ, et al. Microbubble dynamics visualized
in the intact capillary circulation. J Am Coll Cardiol 1984;4:595–600.
7. Skyba DM, Jayaweera AR, Goodman NC, et al. Quantification of
myocardial perfusion with myocardial contrast echocardiography dur-
ing left atrial injection of contrast: implications for venous injection.
Circulation 1994;90:1513–21.
8. Wei K, Jayaweera AR, Firoozan S, et al. Quantification of myocardial
blood flow with ultrasound-induced destruction of microbubbles admin-
istered as a constant venous infusion. Circulation 1998;97:473–83.
9. Tomita S, Mickle DA, Weisel RD, et al. Improved heart function with
myogenesis and angiogenesis after autologous porcine bone marrow
stromal cell transplantation. J Thorac Cardiovasc Surg 2002;123:1132–40.
0. Linka AZ, Sklenar J, Wei K, et al. Assessment of transmural
distribution of myocardial perfusion with contrast echocardiography.
Circulation 1998;98:1912–20.
1. Mills JD, Fischer D, Villanueva FS. Coronary collateral development
during chronic ischemia: serial assessment using harmonic myocardial
contrast echocardiography. J Am Coll Cardiol 2000;36:618–24.
2. Galiuto L, DeMaria AN, del Balzo U, et al. Ischemia-reperfusion
injury at the microvascular level: treatment by endothelin A-selective
antagonist and evaluation by myocardial contrast echocardiography.
Circulation 2000;102:3111–6.
3. Alwyn D’Sa. Acoustic Densitometry. Andover, MA: Agilent Tech-
nologies, 2000.
4. Li RK, Weisel RD, Mickle DA, et al. Autologous porcine heart cell
transplantation improved heart function after a myocardial infarction.
J Thorac Cardiovasc Surg 2000;119:62–8.
5. Kim EJ, Li RK, Weisel RD, et al. Angiogenesis by endothelial cell
transplantation. J Thorac Cardiovasc Surg 2001;122:963–71.
6. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of
endothelial progenitor cells responsible for postnatal vasculogenesis in
physiological and pathological neovascularization. Circ Res 1999;85:
221–8.
7. Firschke C, Linder JR, Wei K, et al. Myocardial perfusion imaging in
setting of coronary artery stenosis and acute myocardial infarction
using venous injection of a second-generation echocardiographic
contrast agent. Circulation 1997;96:959–67.
8. Procop DJ. Marrow stromal cells nonhematopoetic tissues. Science
1997;276:71–4.
